Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01052922 · ClinicalTrials.gov registry record · NA
Systems of Support (SOS) to Increase Colon Cancer Screening and Follow-up Supplement
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 2,260
- Enrollment target
NCT01052922: Completed NA study, sponsored by Kaiser Permanente.
NCT01052922 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 2,260 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01052922, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,260 participants
- Enrollment target
Study Summary
Ancillary Aim #1 We will evaluate intervention effects by comparing binary outcomes for screening (yes/no) in the primary SOS study. In this aim, we propose to calculate actual screening rates by use of time-to-event analyses (also known as survival analysis). The outcome variable of interest is the first time since randomization to have CRCS, either based on FOBT, FS, or CS. Knowing screening rates will not only enable us to make comparisons between groups, but also over time. Ancillary Aims #2 and #3 We will recruit additional participants for two ancillary study aims. First, we will enroll patients age 50-74 years using the same criteria as for the primary SOS study, which includes neither history of colorectal cancer nor evidence of life-limiting disease. Participants who return the questionnaire, consent and considered eligible will be randomized to receive one of three different at-home fecal test kits. The kits will be returned to the GH centralized laboratory, and participants will be informed about lab results using standard GH pathways. Participants who have a test-positive will receive a series of two follow-up surveys (first at 1-2 weeks post result and second at 4-months post result). A comparison group of test-negative results will be matched based on selected criteria, and this group will also receive the follow-up surveys. Participants at both time intervals who do not return the survey via mail will be called and if available, administered the questionnaire via phone.
Interventions
- OTHER 3 sample g-SENSA
- OTHER 2 sample InSure
- OTHER 1 sample OC-Micron
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,260 participants |
| Start Date | 2009-08 |
| Est. Completion | 2011-12 |
| Phase | NA |
What the finished NCT01052922 record still lists
NCT01052922 is an interventional study that assigns participants to a tested intervention. Its 2,260 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% higher).
The record links to 0 conditions, and to 3 interventions - of which 3 sample g-SENSA is the first listed.
NCT01052922 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01052922 about?
NCT01052922 is a clinical study titled "Systems of Support (SOS) to Increase Colon Cancer Screening and Follow-up Supplement". Ancillary Aim #1 We will evaluate intervention effects by comparing binary outcomes for screening (yes/no) in the primary SOS study. In this aim, we propose to calculate actual screening rates by use of time-to-event analyses (also known as survival analysis). The outcome variable of interest is the...
What is the current status of trial NCT01052922?
This trial is currently completed. It is a NA study. The enrollment target is 2,260 participants. The study started on 2009-08. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01052922?
The interventions under investigation include: 3 sample g-SENSA (OTHER), 2 sample InSure (OTHER), 1 sample OC-Micron (OTHER).
Who is sponsoring clinical trial NCT01052922?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01052922's enrollment target sits among peer trials
2,260 48th of 2000 higher than 1,953 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03968393 · 2,270 participants · Phase 4
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
- NCT04889872 · 2,250 participants · NA
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
- NCT06805513 · 2,250 participants · Phase 3
Actual Use Trial of Tadalafil 5 mg
- NCT06939803 · 2,236 participants · NA
AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia